|
GATAD2A expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.89588361571214E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.97950000624792E-09 |
| Normal-vs-Stage2 |
1.2656000025757E-08 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
6.12340000039069E-07 |
| Stage1-vs-Stage2 |
3.980200E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
8.220000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
5.688400E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00380037615366E-10 |
| Normal-vs-AfricanAmerican |
2.14239999962729E-07 |
| Normal-vs-Asian |
1.28519999997856E-06 |
| Caucasian-vs-AfricanAmerican |
9.778200E-01 |
| Caucasian-vs-Asian |
9.117000E-01 |
| AfricanAmerican-vs-Asian |
7.183800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.68319999552347E-09 |
| Normal-vs-Female |
2.46358489164322E-13 |
| Male-vs-Female |
3.348600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.59140000014035E-07 |
| Normal-vs-Extreme_Weight |
1.23480115021835E-11 |
| Normal-vs-Obese |
2.397200E-04 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
3.079800E-02 |
| Normal_Weight-vs-Obese |
1.815980E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
8.564800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.237099999995E-05 |
| Normal-vs-Age(41-60Yrs) |
4.60500000354358E-08 |
| Normal-vs-Age(61-80Yrs) |
6.04529981629298E-10 |
| Normal-vs-Age(81-100Yrs) |
1.009540E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.445000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.073800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.235600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.500200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.308800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.270200E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
4.483700E-02 |
| Normal-vs-Grade 3 |
5.233800E-04 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
8.476300E-02 |
| Grade 2-vs-Grade 4 |
4.483700E-02 |
| Grade 3-vs-Grade 4 |
5.233800E-04 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69364522406568E-12 |
| Normal-vs-N1 |
2.8874000002066E-07 |
| N0-vs-N1 |
2.661400E-01 |
|
|
